- Home
- EWTX vs MRC Comparison
EWTX vs MRC Comparison
Compare EWTX & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- MRC
- Stock Information
- Founded
- EWTX 2017
- MRC 1921
- Country
- EWTX United States
- MRC United States
- Employees
- EWTX N/A
- MRC N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- MRC Industrial Machinery/Components
- Sector
- EWTX Health Care
- MRC Industrials
- Exchange
- EWTX Nasdaq
- MRC Nasdaq
- Market Cap
- EWTX 1.2B
- MRC 1.1B
- IPO Year
- EWTX 2021
- MRC 2012
- Fundamental
- Price
- EWTX $14.28
- MRC $12.41
- Analyst Decision
- EWTX Buy
- MRC Strong Buy
- Analyst Count
- EWTX 8
- MRC 3
- Target Price
- EWTX $40.13
- MRC $15.00
- AVG Volume (30 Days)
- EWTX 1.1M
- MRC 712.6K
- Earning Date
- EWTX 05-08-2025
- MRC 05-06-2025
- Dividend Yield
- EWTX N/A
- MRC N/A
- EPS Growth
- EWTX N/A
- MRC N/A
- EPS
- EWTX N/A
- MRC N/A
- Revenue
- EWTX N/A
- MRC $2,946,000,000.00
- Revenue This Year
- EWTX N/A
- MRC $4.95
- Revenue Next Year
- EWTX N/A
- MRC $6.71
- P/E Ratio
- EWTX N/A
- MRC $24.63
- Revenue Growth
- EWTX N/A
- MRC N/A
- 52 Week Low
- EWTX $10.60
- MRC $9.23
- 52 Week High
- EWTX $38.12
- MRC $15.41
- Technical
- Relative Strength Index (RSI)
- EWTX 43.22
- MRC 53.58
- Support Level
- EWTX $13.80
- MRC $12.04
- Resistance Level
- EWTX $14.68
- MRC $12.74
- Average True Range (ATR)
- EWTX 0.78
- MRC 0.27
- MACD
- EWTX 0.08
- MRC -0.06
- Stochastic Oscillator
- EWTX 29.68
- MRC 28.46
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About MRC MRC Global Inc.
MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.